BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 15800339)

  • 1. Adjuvant interferon therapy for melanoma.
    Hancock B; Wheatley K; Ives N; Gore M
    J Clin Oncol; 2005 Apr; 23(10):2431; author reply 2431-2. PubMed ID: 15800339
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
    Schuchter LM
    J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of interferon alfa as adjuvant therapy for advanced cutaneous melanoma: the need for more evidence.
    Kimyai-Asadi A; Usman A
    J Am Acad Dermatol; 2000 Oct; 43(4):708-11. PubMed ID: 11004636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2b.
    Moschos SJ; Kirkwood JM; Konstantinopoulos PA
    J Clin Oncol; 2004 Jan; 22(1):11-4. PubMed ID: 14665613
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant high-dose interferon-alpha therapy for high-risk melanoma.
    Kirkwood JM; Tarhini AA
    Forum (Genova); 2003; 13(2):127-40; quiz 187-8. PubMed ID: 14732880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy for malignant melanoma.
    Stoutenburg JP; Schrope B; Kaufman HL
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant use of interferon alpha 2b is not justified in patients with stage IIb/III melanoma.
    Bajetta E
    Nat Clin Pract Oncol; 2008 Jan; 5(1):4-5. PubMed ID: 18043604
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2008 Apr; 18(2):152-60. PubMed ID: 18337653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Need for a quantitative meta-analysis of trials of adjuvant interferon in melanoma.
    Wheatley K; Ives N; Hancock B; Gore M
    J Clin Oncol; 2002 Oct; 20(19):4120-1; author reply 4121-2. PubMed ID: 12351611
    [No Abstract]   [Full Text] [Related]  

  • 10. How does interferon work? Does it even matter?
    Sondak VK
    Cancer; 2002 Sep; 95(5):947-9. PubMed ID: 12209676
    [No Abstract]   [Full Text] [Related]  

  • 11. Use and abuse of statistics in evidence-based medicine.
    Kirkwood JM; Ibrahim J; Sondak VK; Ernstoff MS; Flaherty L; Haluska FJ
    J Clin Oncol; 2002 Oct; 20(19):4122-3; author reply 4123-4. PubMed ID: 12351612
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized trials in melanoma: an update.
    Eggermont AM
    Surg Oncol Clin N Am; 2006 Apr; 15(2):439-51. PubMed ID: 16632225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of primary and regional melanoma].
    Dreno B
    Rev Prat; 2004 Jun; 54(11):1203-9. PubMed ID: 15496027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current therapy of carcinoma of the skin].
    Dummer R; Goldinger SM; Sailer E; French LE
    Ther Umsch; 2010 Sep; 67(9):447-52. PubMed ID: 20806173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current management of melanoma: benefits of surgical staging and adjuvant therapy.
    McMasters KM; Swetter SM
    J Surg Oncol; 2003 Mar; 82(3):209-16. PubMed ID: 12619066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon alpha as adjuvant postsurgical treatment of melanoma: a meta-analysis.
    Pirard D; Heenen M; Melot C; Vereecken P
    Dermatology; 2004; 208(1):43-8. PubMed ID: 14730236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [To outwit melanoma with its own tricks].
    Bischoff A
    MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
    [No Abstract]   [Full Text] [Related]  

  • 18. [Underutilization of anticancer agents--an example].
    StrannegÄrd O; Thorén FB
    Lakartidningen; 2010 Dec 8-14; 107(49):3150; discussion 3150-1. PubMed ID: 21280349
    [No Abstract]   [Full Text] [Related]  

  • 19. Current therapy of cutaneous melanoma.
    Mays SR; Nelson BR
    Cutis; 1999 May; 63(5):293-8. PubMed ID: 10349545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy for melanoma.
    Sondak VK
    Cancer J; 2001; 7 Suppl 1():S24-7. PubMed ID: 11504282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.